Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00064870 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Alzheimer's Disease Genetics Study

Name: Alzheimer's Disease Genetics Study — clinical trial record (NCT00064870)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: NCRAD

StatusRecruiting

PhaseNot specified

SponsorIndiana University

Started2002-06

View on ClinicalTrials.gov ↗

The purpose of the Alzheimer's Disease Genetics Study is to identify the genes that are responsible for causing Alzheimer's Disease (AD). One of the ways in which the risk factor genes for late onset AD can be investigated is by identifying and collecting genetic material from families with multiple members diagnosed with AD or dementia.

Amendment history 2 changes detected by DataLookout

2026-09-09

Primary completion pushed: 2026-07 → 2031-08

2026-09-09

Completion pushed: 2026-07 → 2031-08

Trial Details

NCT Number	NCT00064870
Lead Sponsor	Indiana University Collaborators: National Institute on Aging (NIA)
Conditions	Alzheimer Disease, Late Onset Alzheimer Disease, Dementia
Enrollment	10,000 participants
Start Date	2002-06
Primary Completion	2031-08 (estimated)
Study Completion	2031-08 (estimated)
Updated on ClinicalTrials.gov	2026-09-08